We are live on ! Find out more
RTM

Red Tree Management Portfolio holdings

AUM $147M
1-Year Est. Return 202.18%
This Fund
S&P 500
This Quarter Est. Return
+35.01%
1 Year Est. Return
+202.18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$147M
AUM Growth
+$35.5M
Cap. Flow
-$156K
Cap. Flow %
-0.11%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
BCAX
Bicara Therapeutics
BCAX
+$156K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCAX
1
Bicara Therapeutics
BCAX
$1.7B
$93.9M 63.77%
3,163,517
-6,992
-0.2% -$156K
CBLL
2
CeriBell Inc
CBLL
$673M
$42.9M 29.13%
2,205,661
CTNM
3
Contineum Therapeutics
CTNM
$538M
$10.5M 7.1%
638,158

Similar funds

Red Tree Management's Q2 2026 Portfolio in Review

As of Q2 2026, Red Tree Management held 3 positions worth $147M, up 32% from $112M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 0%. Red Tree Management opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Red Tree Management's biggest Q2 2026 reduction was Bicara Therapeutics, cutting an estimated $156K.
  • Red Tree Management's ten largest holdings make up 100% of its $147M portfolio in Q2 2026.
  • Red Tree Management opened 0 new positions and closed 0 in Q2 2026.
  • Red Tree Management's portfolio value rose 32% quarter-over-quarter to $147M.

Based on Red Tree Management's 13F filing for Q2 2026, filed 22 Jul 2026.